Roka Furadada, founded in 2019 and headquartered in Spain, has emerged as a significant player in the healthcare and dermatological sectors. Emphasizing research and innovation, their mission is clear: to reduce skin cancer incidence through the development of active ingredients and medical devices.
Their flagship product, the SMART UV filter, represents a breakthrough in sun protection technology. This intelligent ultraviolet radiation filter harnesses novel molecules with therapeutic properties, aiming to both prevent and treat conditions related to sun exposure.
In June 2021, Roka Furadada secured a €1.73M Series A investment, a testament to its pioneering approach and potential market impact. The backing from the European Innovation Council underscores confidence in their mission and technical prowess.
As a Catalonia Exponential Leader 2023, the company is primed for growth, presenting a promising opportunity for investors seeking a foothold in innovative health solutions.